Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Ghislaine Cherel"'
Publikováno v:
PLoS ONE, Vol 7, Iss 9, p e45111 (2012)
Factor X (FX), a plasma glycoprotein playing a central role in coagulation has a long circulatory half-life compared to closely related coagulation factors. The activation peptide of FX has been shown to influence its clearance with two N-glycans as
Externí odkaz:
https://doaj.org/article/998d4d7e17784cbd9818af40362ee833
Autor:
Sebastien Verhenne, Marc Trossaert, Vincent Muczynski, Caterina Casari, Peter J. Lenting, Laurence Panicot-Dubois, Cécile V. Denis, Christophe Dubois, Ghislaine Cherel, Paul Gueguen, Olivier D. Christophe
Publikováno v:
Thrombosis and Haemostasis
Thrombosis and Haemostasis, 2019, 119 (12), pp.1981-1993. ⟨10.1055/s-0039-1697662⟩
Thrombosis and Haemostasis, Schattauer, 2019, 119 (12), pp.1981-1993. ⟨10.1055/s-0039-1697662⟩
Thrombosis and Haemostasis, 2019, 119 (12), pp.1981-1993. ⟨10.1055/s-0039-1697662⟩
Thrombosis and Haemostasis, Schattauer, 2019, 119 (12), pp.1981-1993. ⟨10.1055/s-0039-1697662⟩
Engineered recombinant factor X (FX) variants represent a promising strategy to bypass the tenase complex and restore hemostasis in hemophilia patients. Previously, a thrombin-activatable FX variant with fibrinopeptide-A replacing the activation pept
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f086879a881f846bff7a2d619e21b647
https://hal-amu.archives-ouvertes.fr/hal-02570572
https://hal-amu.archives-ouvertes.fr/hal-02570572
Autor:
Nabil G. Seidah, Yannick Bontemps, Abdel-Majid Khatib, Geraldine Siegfried, Fabien Calvo, Ajoy Basak, Nathalie Scamuffa, Ghislaine Cherel, Liming Ma
Publikováno v:
Journal of Clinical Investigation. 118:352-363
The proprotein convertases (PCs) are implicated in the activation of various precursor proteins that play an important role in tumor cell metastasis. Here, we report their involvement in the regulation of the metastatic potential of colorectal tumor
Autor:
Fabrice Thiec, Caroline Fribourg, Ghislaine Cherel, Olivier D. Christophe, James A. Irving, Stéphanie Levigne
Publikováno v:
Journal of Biological Chemistry. 282:31569-31579
Factor Xa (FXa) is a key protease of the coagulation pathway whose activity is known to be in part modulated by binding to factor Va (FVa) and sodium ions. Previous investigations have established that solvent-exposed, charged residues of the FXa alp
Autor:
Cécile Loubière, Amélie Harel, Ghislaine Cherel, Olivier D. Christophe, Amine Bazaa, Peter J. Lenting, Vincent Muczynski, Cécile V. Denis
Publikováno v:
Blood. 127(6)
Beside its classical role in the coagulation cascade, coagulation factor X (FX) is involved in several major biological processes including inflammation and enhancement of virus-induced immune responses. We recently reported that the long circulatory
Autor:
Olivier D. Christophe, Janka Matrai, Marinee Chuah, Jessica Willems, Pieter De Bleser, Melvin Y Rincon, Bing Yan, Caroline Le Guiner, Véronique Blouin, Mario Di Matteo, Gwladys Gernoux, Philippe Moullier, Oumeya Adjali, Inge Petrus, Hanneke Evens, Nisha Nair, Ermira Samara-Kuko, Thierry VandenDriessche, Abel Acosta-Sanchez, Amine Meliani, Federico Mingozzi, Ghislaine Cherel
Publikováno v:
Molecular Therapy
Molecular Therapy, Cell Press, 2014, 22 (9), pp.1605-13. ⟨10.1038/mt.2014.114⟩
MOLECULAR THERAPY
Molecular Therapy, 2014, 22 (9), pp.1605-13. ⟨10.1038/mt.2014.114⟩
Molecular Therapy, Cell Press, 2014, 22 (9), pp.1605-13. ⟨10.1038/mt.2014.114⟩
MOLECULAR THERAPY
Molecular Therapy, 2014, 22 (9), pp.1605-13. ⟨10.1038/mt.2014.114⟩
International audience; The robustness and safety of liver-directed gene therapy can be substantially improved by enhancing expression of the therapeutic transgene in the liver. To achieve this, we developed a new approach of rational in silico vecto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1f65dbbfc5886c60eb312eef988d094
https://hal.archives-ouvertes.fr/hal-02881197
https://hal.archives-ouvertes.fr/hal-02881197
Autor:
Ghislaine Cherel, M. E. Briquel, Koen Mertens, Peter J. Lenting, Dominique Meyer, Mariëtte Boon-Spijker, Jenny Goudemand, Ria C. Boertjes, Arja de Goede-Bolder, Olivier D. Christophe, Roseline d'Oiron, Solange Gaillard, Jean-Maurice Lavergne
Publikováno v:
Blood, 98(5), 1416-1423. American Society of Hematology
Development of inhibitory antibodies is a serious complication of treatment with repeated factor IX infusions in a minority of patients with hemophilia B. Such antibodies detected in 8 patients have been characterized. Typing studies revealed that pa
Autor:
Toshiya Nishikubo, Jean-Pierre Girma, Ghislaine Cherel, Geneviève Piétu, Christine Rouault, Anne-Sophie Ribba, Dominique Meyer, Virginie Siguret, Bernadette Obert, Olivier D. Christophe
Publikováno v:
ResearcherID
SummaryThe interacting domain of vWF with platelet GPIb has been shown to overlap the large A1 loop formed by the intra-chain disulfide bond linking Cys 509 to Cys 695. In order to further investigate the role of the conformation of this region, we h
Autor:
Dominique Meyer, A Derlon, Virginie Siguret, Anne-Sophie Ribba, Jean-Maurice Lavergne, Jean-Pierre Girma, Olivier D. Christophe, Geneviève Piétu, Ghislaine Cherel
Publikováno v:
ResearcherID
Type IIA and IIB von Willebrand disease (vWD) result from qualitative abnormalities of von Willebrand factor (vWF) characterized by an absence in plasma of high molecular weight vWF multimers and an abnormal reactivity of vWF towards platelet glycopr
Publikováno v:
The Journal of biological chemistry. 278(12)
Factor X (FX) has high structure homology with other proteins of blood coagulation such as factor IX (FIX) and factor VII (FVII). These proteins present at their amino-terminal extremity a gamma-carboxyglutamic acid containing domain (Gla domain), fo